Generation Bio to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Generation Bio Co. (Nasdaq: GBIO) has announced that its CEO, Geoff McDonough, will be presenting at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 11:30 a.m. ET. The presentation will be accessible via a live webcast on the company’s investor website, with a replay available for 30 days after.

Generation Bio specializes in non-viral gene therapies aimed at providing durable treatments for various diseases. Their innovative platform employs closed-ended DNA (ceDNA) and a cell-targeted lipid nanoparticle system to enhance gene delivery and efficacy.

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, at 11:30 a.m. ET.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is designed to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The company’s efficient, scalable manufacturing process supports Generation Bio’s mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world.

For more information, please visit www.generationbio.com.

Contact:

Investors 
Maren Killackey
Generation Bio
mkillackey@generationbio.com
541-646-2420

Media 
Alicia Webb
Generation Bio
awebb@generationbio.com
847-254-4275

Stephanie Simon
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

FAQ

What date is Generation Bio presenting at the Jefferies Virtual Healthcare Conference?

Generation Bio will present on June 3, 2021.

What time is the Generation Bio presentation scheduled?

The presentation is scheduled for 11:30 a.m. ET.

How can I watch the Generation Bio presentation?

The presentation can be watched live on the investor section of Generation Bio's website.

What is the focus of Generation Bio's gene therapy platform?

Generation Bio focuses on creating non-viral gene therapies for durable and redosable treatments.

What technology does Generation Bio use for gene delivery?

The company uses a proprietary platform that includes closed-ended DNA (ceDNA) and a cell-targeted lipid nanoparticle delivery system.